- Share Price
- $29.18
- Dividend Yield
- 5.93%
- Track Record
- 15 Years of Consecutive Dividend Growth
- Payout Ratio
- -2,800.0%
- Consensus Rating
- Moderate Buy
- Consensus Price Target
- $34.54 (18.4% Upside)
About Pfizer
Pfizer Inc discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
Read More
